Eye diseases are widespread around the globe. According to the World Health Organization, the most important three eye diseases or conditions that are a potential threat to the global population are diabetic retinopathy, glaucoma, and age-related macular degeneration. One more vital reason for visual harm is refractive errors. Some of the important reasons for vision loss or low vision are age, healthcare, gender, genetic problems and the prevalence of family history.
Researchers have created a novel gene therapy approach that shows promise for someday treating an eye disease that results in progressive vision loss.
A new study led by Boston Medical Center researchers indicates a well-known biomarker that serves as a marker for earlier diagnosis of neurodegenerative diseases is now detectable in the eye.
New insight on how people with retinal degenerative disease can maintain their night vision for a relatively long period of time has been published today in the open-access eLife journal.
According to a study the enzyme called serine palmitoyl-transferase can be utilized as a metabolically responsive “switch” that reduces the growth of tumor.
One of the immune system's oldest branches may be influencing the severity of COVID disease, according to a new study from researchers.
Thanks to the interesting group of trefoil factor peptides, both industry and research could usher in better treatments for chronic disorders.
New understandings of how lipids function within tears could lead to better drugs for treating dry eye disease.
Nagano prefecture is home to a group of people effected with a rare genetic neurodegenerative disorder called familial amyloid polyneuropathies. This disease impacts the gene encoding protein transthyretin which is produced in the liver and also eyes.